XML 24 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Interim Statements of Cash Flows - CAD ($)
9 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from (used in) operating activities    
Net loss $ (15,539,401) $ (31,667,877)
Add items not affecting cash    
Share-based payments 1,135,413 2,510,322
Foreign exchange (5,324,298) (129,395)
Amortisation - pilot plant 206,732 11,249,269
Amortisation - intangible assets 89,294 143,407
Amortisation - office lease 156,117 51,840
Interest expense 21,469 10,106
Net changes in non-cash working capital items to operations:    
Receivables 472,864 (51,891)
Prepaid expenses (1,708,501) (1,758,404)
Accounts payable and accrued liabilities (503,314) 1,271,411
Compensation shares issued   500,000
Net cash used in operating activities (20,993,625) (17,871,212)
Cash flows used in investing activities    
Exploration and evaluation assets (15,806,296) (2,069,120)
Pilot plant   (666,308)
Commercial plant development (9,343,585) (983,062)
Aqualung Carbon Capture pilot plant development (1,754,676)  
Patent (39,864)  
Net cash used in investing activities (26,944,421) (3,718,490)
Cash flows from financing activities    
Proceeds from private placement   120,452,352
Share issuance costs   (255,431)
Exercise of warrants   7,389,127
Exercise of options 5,257,000 2,986,499
Lease payments (170,776) (57,986)
Net cash from financing activities 5,086,224 130,514,561
Effect of exchange rates on cash 5,208,648  
Net change in cash (37,643,174) 108,924,859
Cash, beginning of period 129,065,348 27,988,471
Cash, end of year $ 91,422,174 $ 136,913,330